Psychosis with Coexisting Substance Misuse -  National Collaborating Centre for Mental Health (NCCMH)

Psychosis with Coexisting Substance Misuse

The NICE Guideline on Assessment and Management in Adults and Young People
Media-Kombination
326 Seiten
2011 | First
RCPsych Publications
978-1-908020-30-7 (ISBN)
62,40 inkl. MwSt
  • Keine Verlagsinformationen verfügbar
  • Artikel merken
Around 40% of people experiencing psychosis also misuse drugs or alcohol at some point in their lives, which can complicate treatment and lead to serious health and social problems. This gives recommendations on how to best manage people with psychosis and coexisting substance misuse so they receive evidence-based care for both conditions.
Around
40% of people experiencing psychosis also misuse substances at some point in
their lives, which can lead to serious health and social problems for the
person and complicate their treatment.





This
new guideline covers the assessment and management of adults and young people
(aged 14 years and older) who have a clinical diagnosis of psychosis
(schizophrenia, bipolar disorder or other affective psychosis) and coexisting
substance misuse (harmful use of any psychotropic substance including alcohol
and legal or illicit drugs).





Although
separate NICE guidelines have been
developed for the management of schizophrenia, bipolar disorder and drug and
alcohol misuse, the importance of this new guideline on psychosis and substance
misuse is in offering advice on how to integrate treatment for people with these
commonly coexisting conditions.





The
guideline includes comprehensive reviews of assessment, care pathways and
service delivery models, psychological and pharmacological interventions for
both conditions, and treatment and services for young people.

The National Collaborating Centre for Mental Health (NCCMH) was established in 2001 by the UK-based National Institute for Health and Clinical Excellence (NICE) to develop guidance on the appropriate treatment and care of people with mental health problems and then write the clinical guidelines. The NCCMH is a partnership between the Royal College of Psychiatrists and the British Psychological Society.

Contents


Preface

Psychosis with coexisting substance misuse

Method used to develop this guideline

Experience of care

Assessment and care pathways

Service delivery models

Psychological and psychosocial interventions

Pharmacological and physical interventions

Young people with psychosis and coexisting substance misuse

Summary of recommendations

Appendices

References

Abbreviations

Erscheint lt. Verlag 1.11.2011
Reihe/Serie NICE Guidelines
Verlagsort London
Sprache englisch
Maße 170 x 240 mm
Gewicht 578 g
Themenwelt Geisteswissenschaften Psychologie Psychosen
Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Medizin / Pharmazie Medizinische Fachgebiete Suchtkrankheiten
ISBN-10 1-908020-30-X / 190802030X
ISBN-13 978-1-908020-30-7 / 9781908020307
Zustand Neuware
Haben Sie eine Frage zum Produkt?